Neurontin vs gabapentin
Pro Research Analysisby 
Searched over 200M research papers
Neurontin vs Gabapentin: A Comparative Analysis
Bioequivalence and Switchability of Gabapentin Formulations
Bioequivalence of Neurontin and Gabasandoz
A study investigated the bioequivalence of Neurontin and Gabasandoz, two formulations of gabapentin, using an individual bioequivalence (IBE) study design. The results demonstrated that both formulations are bioequivalent, with negligible subject-by-formulation variability compared to within-subject variability. This indicates that switching between Neurontin and Gabasandoz should not affect clinical outcomes, making them interchangeable for patients .
Pharmacological Properties and Mechanism of Action
Antihyperalgesic and Antiepileptic Effects
Gabapentin, marketed as Neurontin, is known for its antiepileptic and antihyperalgesic properties. It binds to the α2δ subunit of voltage-dependent calcium channels, which is crucial for its therapeutic effects. Studies have shown that gabapentin effectively reduces pain in inflammatory models and does not induce tolerance, unlike opioids . Additionally, gabapentin has been found to inhibit the release of neurotransmitters like norepinephrine and glutamate, which may contribute to its efficacy in treating various neurological conditions 710.
Efficacy in Treating Partial Seizures
Gabapentin has been evaluated as an add-on therapy for patients with refractory partial seizures. Clinical trials have shown that gabapentin significantly reduces seizure frequency compared to placebo, with a responder rate of 22.9% at a dose of 900 mg/day. The drug is generally well-tolerated, with common side effects including somnolence, dizziness, and fatigue .
Clinical Applications and Limitations
Treatment of Postherpetic Neuralgia
Neurontin was the first FDA-approved drug for postherpetic neuralgia (PHN). The immediate-release (IR) formulation requires multiple daily doses, whereas a gastroretentive (GR) formulation, Gralise, allows for once-daily dosing with improved tolerability. The GR formulation takes advantage of gastrointestinal physiology to enhance drug absorption and maintain therapeutic levels .
Ineffectiveness in Treating Tinnitus
A clinical trial aimed at evaluating gabapentin's efficacy in treating tinnitus found no significant difference between the drug and placebo groups. This suggests that gabapentin may not be effective for this condition, highlighting the importance of targeted therapeutic applications .
Abuse Potential and Safety Concerns
Abuse and Diversion
Gabapentin is generally considered to have a low potential for abuse. However, there have been reports of its misuse, particularly among nonmedical prescription opioid users. This underscores the need for careful monitoring and regulation to prevent diversion and abuse .
Conclusion
Gabapentin, marketed as Neurontin, is a versatile drug with proven efficacy in treating epilepsy, neuropathic pain, and other neurological conditions. Its bioequivalence with generic formulations like Gabasandoz ensures flexibility in clinical practice. While it shows promise in various therapeutic areas, its limitations, such as ineffectiveness in treating tinnitus and potential for abuse, must be considered. Overall, gabapentin remains a valuable tool in the management of several chronic conditions.
Sources and full results
Most relevant research papers on this topic